For our closing note, the FTSE 100 has finished the day 0.38 per cent down, but still clocks a week more than 1.3 per cent up ...

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase ...

The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...

AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for adeno-associated virus (AAV) capsids from existing ...

Asia stock markets closed higher and the FTSE 100 index today held its ground after President Trump issued letters warning of ...

Hiroshi Watanabe/DigitalVision via Getty Images Most major stock indexes across the globe ended the week higher, following ...

Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...

Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...

At the Paris Air Show at Le Bourget, Orbex chief executive Miguel Bello Mora announced that the company is now targeting next ...

Gilt yields spike on Reeves exit speculation and CEO of AstraZeneca discusses leaving London - Stock markets updates and ...